Well Q2 ends in a little over three weeks. According to Dr. Hirsch and the written timeline we should be hearing about the Phase I safety study any day now. Also potentially more about our sublingual tablets and nasal spray. A patent could be granted at any time and perhaps a new patent application filed for another indication we might be studying... such as acne. That is pure speculation on my part.